ROCKWELL MEDICAL, INC. Restructuring Charges
ROCKWELL MEDICAL, INC. (RMTI) reported Restructuring Charges of $1.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-03-26
- ROCKWELL MEDICAL, INC. restructuring charges for the quarter ending 2025-12-31 was $200.00K.
- ROCKWELL MEDICAL, INC. restructuring charges for the quarter ending 2025-09-30 was $500.00K.
- ROCKWELL MEDICAL, INC. restructuring charges for fiscal 2025 was $1.00M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $700.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.00M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $500.00K 10-Q · filed 2025-11-12 | $800.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |